When was Abzena founded?

Abzena was founded in 2001 and raised its 1st funding round 6 years after it was founded.

Where is Abzena located?

Abzena is headquartered in Cambridge, United Kingdom. It is registered at Babraham Research Campus, Babraham Cambridge CB22 3AT UK.

How many employees does Abzena have?

As of Oct 31, 2026, the latest employee count at Abzena is 447.

Is Abzena a funded company?

Abzena is a funded company, having raised a total of $67.1M across 11 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Jun 20, 2007.

When was the latest funding round of Abzena?

Abzena's latest funding was a $***** Post IPO round on Mar 31, 2022, with participation from 2 investors.

What is the annual revenue of Abzena?

Annual revenue of Abzena is less than £1M as on Dec 31, 2025

Abzena - 2026 Company Profile, Team, Funding & Financials

Abzena is an acquired company based in Cambridge (United Kingdom), founded in 2001. It operates as a Provider of antibody discovery, cell line development, and bio analytics services. Abzena has raised $67.1M in funding from investors like Imperial Innovations, Invesco Perpetual and Mercia.

Company Details

Provider of antibody discovery, cell line development, and bio analytics services. The company mainly provides proprietary technologies, mammalian and bio conjugates manufacturing, peptide synthesis, analytical development, cell line development, and bio assays services.

Website: abzena.com
Social
Email ID: *****@abzena.com
Phone Number: +44 **********
Registered Address: Babraham Research Campus, Babraham Cambridge CB22 3AT UK

Key Metrics

Founded Year

2001

Location

Cambridge, United Kingdom

Stage

Acquired

Total Funding

$67.1M in 11 rounds

Latest Funding Round

Post IPO, Mar 31, 2022, $*****

Investors

Imperial Innovations & 12 more

Annual Revenue

£0 - £1M as on Dec 31, 2025

Employee Count

447 as on Oct 31, 2026

Investment & Acquisitions

PacificGMP

Similar Companies

Anthem Biosciences & 230 more

Exit Details

Acquired by Welsh, Carson, Anderson & Stowe (Aug 16, 2018)

View Abzena's full profile

Abzena is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
ABZENA, INC. CIN: 73-1731905 , United States, Active	Jul 20, 2015	-	217 (As on Dec 31, 2020)	-
ABZENA LIMITED CIN: 8957107 , United Kingdom, Active	Mar 24, 2014	£0 - £1M (As on Dec 31, 2025)	89 (As on Dec 31, 2020)

Abzena got acquired by Welsh, Carson, Anderson & Stowe on Aug 16, 2018 at an acquisition amount of $*****.

Click here to take a look at Abzena's acquisition in detail

Abzena has raised a total funding of $67.1M over 11 rounds. Its first funding round was on Jun 20, 2007. Its latest funding round was a Post IPO round on Mar 31, 2022 for $*****. 2 investors participated in its latest round. Abzena has 13 institutional investors.

Here is the list of recent funding rounds of Abzena:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 31, 2022	4634714	Post IPO	1236239	2683721	6826737	3188538
Jul 28, 2020	3494556	Post IPO	2026434	8096925	3623861	Biospring Partners
Apr 21, 2017	4118652	Post IPO	2113743	7901650	2423460	Touchstone Innovations